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Abstract Calcium phosphate cements (CPCs) are synthetic
bone grafting materials that can be used in fracture stabili-
zation and to ﬁll bone voids after, e.g., bone tumour exci-
sion. Currently there are several calcium phosphate-based
formulations available, but their use is partly limited by a
lack of knowledge of their mechanical properties, in parti-
cular their resistance to mechanical loading over longer
periods of time. Furthermore, depending on, e.g., setting
conditions, the end product of acidic CPCs may be mainly
brushite or monetite, which have been found to behave
differently under quasi-static loading. The objectives of this
study were to evaluate the compressive fatigue properties of
acidic CPCs, as well as the effect of phase composition on
these properties. Hence, brushite cements stored for differ-
ent lengths of time and with different amounts of monetite
were investigated under quasi-static and dynamic com-
pression. Both storage and brushite-to-monetite phase
transformation was found to have a pronounced effect both
on quasi-static compressive strength and fatigue perfor-
mance of the cements, whereby a substantial phase trans-
formation gave rise to a lower mechanical resistance. The
brushite cements investigated in this study had the potential
to survive 5 million cycles at a maximum compressive
stress of 13MPa. Given the limited amount of published
data on fatigue properties of CPCs, this study provides an
important insight into the compressive fatigue behaviour of
such materials.
1 Introduction
Bone tissue has a certain ability to heal by itself, however if
a fracture has reached a critical size, or if the bone tissue is
of poor quality, bone grafting may be needed. The global
market for bone grafts and substitutes was estimated to
almost 2.4 billion US$ in 2014 [1]. With an aging popu-
lation and an increasing number of patients suffering from
osteoporosis the bone graft substitute market is anticipated
to continue to rise [2].
Although autologous tissue is still considered the gold
standard, it has some drawbacks including donor-site mor-
bidity and supply limitation, thus the market for synthetic
materials is steadily growing. Among the synthetic bone
grafting materials, calcium phosphate cements (CPCs) are
an interesting alternative since they can be degradable, are
osteoconductive and can be directly injected into the frac-
ture site [3, 4]. Currently there are several commercial
calcium phosphate based formulations available [5]. Lim-
iting factors for an increased use of CPCs in fracture sta-
bilization and as a bone-void ﬁlling material, include a
strong tradition to use autografts, restricted knowledge
about different synthetic alternatives [6], and, perhaps most
importantly, their mechanical properties [5].
A recent review on ceramic-based cements and putties
pointed out that not only the average compressive strength of
a ceramic cement is of importance when characterizing the
mechanical properties, but also the strength distribution and
the fatigue properties [5]. Moreover, since some bone cement
formulations degrade in physiological solutions, the change in
cement properties over time needs to be studied. The subject
of long-term degradation in terms of quasi-static compressive
strength and porosity has previously been addressed by the
authors [7]. However, there is a scarcity of data on the fatigue
properties of calcium phosphate-based bone cements.
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To the best of the authors’ knowledge there is no study
available on the dynamic mechanical properties of acidic
calcium phosphate cements, i.e., brushite (dicalcium
phosphate dihydrate) or monetite (dicalcium phosphate
anhydrous), and only four studies on the dynamic
mechanical properties of other self-setting calcium
phosphate-based cements alone [8–11]. Zhao et al. studied
a hydroxyapatite cement under cyclic four-point bending,
at 5 Hz, and showed that the cements failed immediately
when stresses ≥6 MPa were applied, whereas they sur-
vived for 2 million cycles (run-out limit) when the cements
were subjected to stress levels ≤5MPa (corresponding to
≤half of the average quasi-static three-point ﬂexural
strength) [8]. Harmata et al. tested a commercially avail-
able biphasic bone cement (PRO-DENSE®, 75 wt% cal-
cium sulphate and 25 wt% brushite with ß-tricalcium
phosphate (ß-TCP) granules), under compressive fatigue at
stress levels between 5–15 MPa, using a frequency of 5 Hz
and a run-out limit of 1 million cycles [9]. They found that
the median fatigue life was 23,500 cycles when a max-
imum stress level of 5 MPa was used, whereas the median
fatigue life was 236 cycles at 10 MPa, and 4 cycles at 15
MPa. No data on the quasi-static properties of the biphasic
bone cement were reported. Fatigue crack growth in cal-
cium phosphate cements has also been studied, by Jew
et al. (commercially available apatite cement, name of
supplier was not speciﬁed) and Morgan et al. (Norian®
SRS®, an apatite-based cement) [10, 11]. The crack
growth threshold value was found to be between 0.08 and
0.11 MPa√m for the two cements, taken at a crack growth
rate of 10−9 m/cycle.
There are also a few publications on the fatigue
properties of CPCs together with human bone, for instance
inside vertebrae [12] and in the tibial plateau [13]. In the
study by Wilke et al., Calcibon®, (apatite cement), was
injected ex vivo into osteoporotic human vertebrae and
subjected to cyclic loading using a frequency of 5 Hz and a
load amplitude between 100 to 600 N. The experimental
set-up allowed for complex loading of the cement-bone
specimens, including both ﬂexion and bending. The authors
concluded that the strength of osteoporotic vertebral bodies
could be maintained during cyclic loading corresponding to
daily walking for a period of about 3 months (run-out was
set to 100,000 cycles), when the calcium phosphate cement
was used as an augmenting material [12]. The quasi-static
strength of Calcibon® was not reported. McDonald et al.
compared Callos® (apatite cement) as a bone augmentation
material to an autologous bone graft for human tibial pla-
teau fractures and found that both materials survived all the
way to run-out (210,000 cycles). However, the tibial plateau
displacement was signiﬁcantly lower for calcium
phosphate-augmented repairs than for those made with the
autograft (in average 1.8 vs. 3.3 mm), and the ultimate
quasi-static load was signiﬁcantly higher (in average 2241
vs. 1717 N for calcium phosphate repairs and autografts,
respectively). Thus, they concluded that the higher fatigue
strength of the calcium phosphate repairs, would increase
the immediate load-bearing capabilities of the tibial plateau
compared to if autografts would be used. The fatigue study
was performed using a frequency of 4 Hz, at a maximum
load representing an in situ load from one to three times
body weight.
A synthetic vertebral bone augmentation model, com-
prising a polyurethane foam cube with a cylindrical hole,
has also been used to study the fatigue performance of
KyphOs™ (apatite cement) [14]. Lewis et al. found that the
cement had a 100% probability of surviving 1 million load
cycles (run-out) when a maximum compressive stress of
1.7 MPa was used, whereas when the load was doubled the
probability was only 28% (median fatigue life 721,919
cycles). All fatigue tests were conducted using a frequency
of 3 Hz. The quasi-static compressive strength of the cement
alone was not reported.
The fatigue properties of CPCs inside animal bone have
also been evaluated. Gisep et al. studied Norian® SRS®
and a calcium sulphate cement in a gap defect in sheep
tibia and found that there were no differences between the
two materials and that cracks started to form after 800
cycles, in both materials, when loads between 1.5–2 kN
were applied [15]. The average quasi-static failure load
was reported to be 3.7 kN for both Norian® SRS® and
calcium sulphate. The frequency used for the fatigue tests
was not speciﬁed.
The fatigue studies performed on CPCs alone, or in
combination with bony tissue, up until now are very limited.
Moreover, there are no fatigue studies available at all on
CPCs where the main phase is the result of an acidic
reaction. This is unfortunate, since recent studies have
indicated two clinical advantages of these types of cements
compared to apatite cements: faster resorption rates [3, 16,
17] and osteoinductive effects [18, 49, 50], permitting faster
bone regrowth. Furthermore, brushite and monetite have
previously been found to display different quasi-static
strengths [19, 20], and it is hence likely that also the fatigue
properties of the cements will differ.
CPCs may be used for direct injection, but also as a pre-
set material in bone scaffolds [18, 19]. However, in brushite
cements the phase composition is only metastable, and may
evolve over time. It is therefore important to also investigate
the inﬂuence of storage time on the phase composition and
the mechanical properties of the cement.
The purpose of this study was to investigate the fatigue
behaviour of acidic CPCs. In order to evaluate the effect of
phase composition on the fatigue properties and quasi-static
strength of the cements, specimens containing different
amounts of monetite were investigated.
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2 Materials and methods
2.1 Cement preparation
The powder phase of the cement consisted of 60 mol% ß-
TCP (Sigma-Aldrich, St. Louis, MO, USA) and 40 mol%
monocalcium phosphate monohydrate (MCPM; Scharlau,
Sentmenat) with the addition of 1 wt% disodium dihydro-
gen pyrophosphate (SPP; Sigma-Aldrich, St. Louis, MO,
USA). SPP was added to the powder mixture to prolong the
setting time of the cement [21]. The powder phase was
manually mixed with double distilled water at a liquid to
powder (L/P) ratio of 0.4 ml/g for 30 s. The cement paste
was cast into rubber moulds (6 mm in diameter) and left to
set for 24 h at 37 °C and 100% humidity. To achieve spe-
cimens with plane parallel end surfaces, the set specimens
were polished with SiC paper to a ﬁnal height of 12 mm
(specimen dimensions according to the standard ASTM F
451-08 [22]). The cement specimens were stored in desic-
cators at room temperature (21 ± 1 °C) until further testing
after 24 h–240 days.
2.2 Specimen examination
All fabricated specimens were visually examined for
external defects. Internal defects were visualized in 2D by
micro computed tomography (SkyScan 1172, Bruker
microCT, Kontich, Belgium) and measured with the control
software of the scanner. Specimens having external or
internal defects with a diameter larger than 1 mm were
rejected for fatigue testing in accordance with ASTM F
2118-03 [23]. The rejection ratio, i.e., the ratio between the
number of discarded specimens and the total number of
specimens, was on average 63%. The rejection ratio prior to
fatigue testing has not been reported for CPCs before, but is
within the range found in the literature for poly(methyl)
methacrylate cements (PMMA, 40–72%) [24–27].
2.3 Phase characterization
The phase composition of the specimens was analysed with
X-ray diffraction (XRD), using a D8 Advance (Bruker,
AXS GmbH, Karlsruhe, Germany) in a theta-theta setup
using Ni-ﬁltered Cu-Kα irradiation. The specimens were
ground and homogenized and diffraction data was collected
from six powder specimens taken at random from this
quantity of ﬁne powder. Diffraction angles 2θ of 10–60°
were analysed in steps of 0.02 degrees with 0.25 s per step,
while rotating the sample at a speed of 80 rpm. Profex
(http://profex.doebelin.org) [28] in combination with
BGMN (http://www.bgmn.de) [29, 30] was used for Riet-
veld reﬁnement of the powder XRD data. Crystalline
models were taken from PDF# 04-013-3344 [31] for
brushite, PDF# 04-009-3755 [32] for monetite, PDF# 04-
008-8714 [33] for β-TCP and PDF# 04-009-3876 [34] for
beta-calcium pyrophosphate (β-CPP; a constituent of the as-
received ß-TCP). No other phases were identiﬁed in the
diffraction patterns. The repeatability of the quantitative
phase composition was taken as 2.77× standard deviation
according to ASTM E177-14 [35, 36].
2.4 Quasi-static compressive strength
The quasi-static strength of the specimens was assessed by
compression testing at 1 mm/min using a materials testing
machine (AGS-X, Shimadzu, Kyoto, Japan) equipped with
a 5 kN load cell. No specimens were excluded from the
quasi-static testing due to external or internal defects (see a
previous section), as exclusion gave the same average
strength (a difference of 0.09–6.0MPa, i.e. within one
standard deviation), but with fewer specimens per group
(2–10 specimens rather than 7–24).
2.5 Fatigue testing
Fatigue tests were performed under ambient conditions on
specimens that had passed the specimen examination, using
a dynamic materials testing system (MTS® Axial 858 Mini
Bionix® II, MTS Systems Corp., Eden Prairie, MN, USA)
equipped with a 5 kN load cell. A cyclic sinusoidal
constant-amplitude compression-compression load was
applied to each specimen, starting from a small preload of
0.5 MPa. A frequency of 5 Hz was used and the maximum
stress level was set to 13 MPa, based on preliminary test-
ing, and similar to what has previously been used for a
calcium sulphate and phosphate-based bone cement [9].
This stress level is also in the range of reported compres-
sive strengths of human trabecular bone (1–23MPa) [37–
39], and higher than what has been suggested for fatigue
testing of materials for spinal applications (5 MPa) [40]—
one suggested use for ceramic cements in load-bearing
applications is vertebroplasty [14, 41]. The specimens were
tested until catastrophic failure, i.e., until occurrence of a
sudden drop in stress, or a run-out of 5 million cycles, as




The Rietveld reﬁnement calculations showed that the
cements contained approximately 71 wt% brushite and 3 wt
% monetite initially (after 24 h of setting and 1 day of
storage), see Figs. 1, 2a. As the amount of monetite
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increased a concomitant decrease in brushite was seen, and
eventually the brushite-to-monetite transformation reached
a reversed relationship compared to the starting material
(~67 wt% monetite and ~2 wt% brushite), see Figs. 1, 2b.
Approximately the same amount of ß-TCP (about 20 wt%)
and ß-CPP (about 7 wt%) could be found in all cement
specimens. Repeatability for all phases was better than
1.4 wt%.
3.2 Quasi-static compressive strength
The compressive strength for specimens set for 24 h and
stored for 1 day, and containing approx. 3 wt% monetite,
was on average 14.0± 3.5 MPa, see Fig. 3. As the storage
time increased and the specimens dried, the quasi-static
compressive strength increased twofold, to 29.4± 8.0 MPa.
These specimens contained up to 23 wt% monetite. For
specimens containing higher amounts of monetite (>50 wt
%) the quasi-static compressive strength was on average
13.0± 2.8 MPa.
3.3 Fatigue
A large scatter in the fatigue results was found, as a function
of storage time and monetite content, see Fig. 4. Right after
fabrication (24 h of setting and 1 day of storage, specimens
containing approximately 3 wt% monetite) most specimens
survived between a few cycles up to 1000 cycles, however
one specimen survived 5 million cycles (un-ﬁlled circles in
Fig. 4). Longer storage times allowed for the specimens to
dry and led to an increase in the number of cycles to failure,
Nf, (from approximately 800,000 to run-out) up to a mon-
etite content of approximately 23 wt%. As the brushite-to-
monetite conversion progressed and reached levels of
50 wt% monetite, the specimens only survived a few up to
1000 cycles.
4 Discussion
In this study, the effect of phase composition of acidic
CPCs on the quasi-static compressive strength and com-
pressive fatigue resistance was investigated.
Storing the specimens led to changes in phase compo-
sition of the cements, with a transformation of brushite into


















Fig. 1 Reference patterns for identiﬁed phases and representative
XRD patterns of specimens containing different amounts of monetite
 






























Fig. 2 Rietveld reﬁnement of the XRD patterns of a specimens con-
taining approximately 3 wt% monetite and b specimens containing
approximately 67 wt% monetite demonstrates good agreement of the
calculated and measured intensities for all four phases. The reﬁnement
quality is representative for all datasets included in this study
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monetite with time (Fig. 1). It has previously been shown
that higher temperatures promote the transformation from
brushite to monetite [20, 42]. Moreover, a dry atmosphere is
likely to also affect the decomposition. Storing the speci-
mens in desiccators at a stable temperature gave an increase
in monetite content over the time of storage (up to
240 days).
The quasi-static compressive strength was affected by a
dual effect of both drying and brushite-to-monetite phase
transformation (Fig. 3). The strength of CPCs has pre-
viously been shown to, in general, be lower for wet speci-
mens compared to dry specimens [43–46]. Specimens
containing approximately 3 wt% monetite (specimens set
for 24 h and stored for 1 day) were likely still moist when
tested in compression, thus resulting in lower strengths. As
the cement specimens dry the strength of the cement is
expected to be higher, as was demonstrated for specimens
containing lower amounts of monetite (up to 23 wt%).
However, for specimens having monetite as the main phase
the strength was similar to that of the moist specimens
(see Fig. 3). Indeed, decomposition of brushite into mon-
etite has been found to increase the porosity of the cement
and thus have an adverse effect on the mechanical proper-
ties [19, 20, 47].
Fatigue testing of CPCs is prone to result in a large
variation in data, due to the inherent porosity of the cements
as well as surface ﬂaws. However, both storage and brushite-
to-monetite phase transformation had a clear effect on the
fatigue results found in this study. The rather low quasi-
static strength after 24 h of setting and 1 day of storage
resulted in specimens that failed after few loading cycles
(with one exception, un-ﬁlled circles in Fig. 4), what the
authors believe to be an effect of testing specimens that
were still moist from fabrication. As already mentioned,
as the cements dried, the quasi-static compressive strength
of the specimens increased (Fig. 3) and so did the fatigue
life (Fig. 4). The specimens that underwent the highest
conversion from brushite to monetite were however asso-
ciated with lower quasi-static strengths (Fig. 3), and resulted
in earlier failure of the specimens under dynamic loading
(Fig. 4). The fatigue life of the moist cements (those that
were tested 24 h after fabrication and 1 day of storage) and
of those containing mainly monetite was in the same range
as what has previously been found for a calcium sulphate
and phosphate-based cement [9] (from a few cycles to a few
hundred, using a compressive stress of 10–15MPa). How-
ever, for the cements that were dry, and before the phase
transformation from brushite to monetite had progressed too
far, the fatigue life presented herein is higher (800,000—5
million cycles for specimens containing up to 23 wt%
monetite). Moreover, the run-out limit used in the present
study (5 million cycles) is ﬁve times longer compared to
what Harmata et al. used [9], indicating the potential use of
acidic cements in applications where compressive loading
over longer periods of time is expected, e.g., certain types of
constrained vertebral compression fractures. Indeed, CPCs
have successfully been demonstrated to stabilize certain
osteoporotic vertebral fractures and found to be a good
alternative to PMMA cements both ex vivo [48] and in vivo
[41]. It should be noted however, that the current testing was
performed in air, and chemical degradation in vivo is likely
to have a strong effect on the mechanical properties of the
cements, as further discussed below.
The present study made evident that for pre-set cement
scaffolds it is important to control the phase composition of
the cements, since it can be detrimental to the mechanical
performance under quasi-static compression, as well as
under compressive fatigue.

























Fig. 3 Quasi-static compressive strength as a function of monetite
content. Specimens that were tested after 24 h of setting and 1 day of
storage are shown as un-ﬁlled boxes, all other tested specimens are
shown as ﬁlled boxes. n ≥ 7, per box
Fig. 4 Number of cycles to failure, Nf, as a function of monetite
content. Specimens that were tested after 24 h of setting and 1 day of
storage are shown as un-ﬁlled circles, all other tested specimens are
shown as ﬁlled circles. The dashed line indicates the run-out limit (5
million cycles)
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One limitation of the study is that the number of tested
specimens in fatigue was low and only one maximum stress
level was evaluated. On the other hand, results from quasi-
static compression and phase composition were based on a
larger number of replicates. The authors believe that the
clear correlations seen between phase composition, quasi-
static strength and fatigue, and the scarcity of fatigue data in
the literature of pure CPCs still lend importance to the
study.
Self-setting CPCs can either be used as pre-set
scaffolds or injected directly into the fracture site. For
both applications, the CPC will be in direct contact with
physiological ﬂuids when implanted into the body. It has
previously been shown that the compressive strength of
brushite cements decreased when the cements were soaked
either in water, PBS or a serum solution over longer
periods of time [7], thus the environment surrounding
the material may also have an inﬂuence on the
compressive fatigue life. Indeed, the fatigue performance of
a hydroxyapatite cement has been evaluated at room tem-
perature in physiological ﬂuid [8] and a biphasic cement,
where the main phase consisted of calcium sulphate, was
tested in dynamic loading under constant hydration [9].
However, none of these studies presented any results
obtained under ambient conditions. Moreover, up until now
there are no publications at all on the fatigue properties of
pure acidic CPCs alone, even though the in vivo loading
scenario is dynamic. Therefore, future studies should
evaluate fatigue of CPCs under ambient conditions as well
as under conditions simulating an in vivo environment,
e.g., keeping the cements wet throughout the study and
performing the fatigue tests in a physiological solution kept
at 37 °C, to be able to investigate the effect of environ-
mental surroundings on the fatigue performance of the
cements.
The presence of ﬂaws in the material, both in the
form of surface defects and pores, is known to affect the
fatigue performance. In this study, specimens having large
internal and surface defects were excluded from the
fatigue tests, as suggested in the standard for fatigue testing
of acrylic bone cements [23]. This exclusion was done in
order to decrease the scatter in the experiment, thus sim-
plifying the analysis. Although not evaluated in this speciﬁc
study, similar cement compositions have shown a porosity
of approximately 39% for specimens containing 3 wt%
monetite and approximately 56% for specimens containing
55 wt% monetite [42]. The above-mentioned publications
on fatigue properties of calcium phosphate-based cements
[8–11] did not evaluate the porosity of the cement speci-
mens. In future studies the porosity of each specimen
should be evaluated in order to assess any correlation
between the porosity and pore size distribution, and the
fatigue properties.
5 Conclusions
In this study, it was found that pre-set acidic cements have
the potential to survive 5 million cycles under compressive-
compressive fatigue at a maximum stress of 13MPa.
However, the fatigue properties were affected by both sto-
rage of the cements and their phase composition. Moist
cements had a lower fatigue resistance compared to cements
that were dry, in accordance with quasi-static compressive
strength results. Moreover, while cements with brushite as
the main phase and monetite amounts of up to approx. 23
wt% did not have a detrimental effect on the fatigue life,
specimens having monetite as the main phase gave a clear
decrease in fatigue properties. The ﬁndings presented herein
are of importance for the increased use of acidic CPCs in
fracture stabilization and as bone-void ﬁlling materials, as
they remedy the current lack of data on fatigue
performance.
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